Grace Therapeutics Inc (GRCE)
3.08
-0.06
(-1.75%)
USD |
NASDAQ |
Nov 05, 16:00
3.08
0.00 (0.00%)
After-Hours: 19:02
Grace Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2021 | -4.91K% |
December 31, 2020 | -3.98K% |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
November 30, 2016 | |
August 31, 2016 | |
May 31, 2016 | |
February 29, 2016 |
Date | Value |
---|---|
November 30, 2015 | -43.18K% |
August 31, 2015 | -17.73K% |
May 31, 2015 | -18.74K% |
February 28, 2015 | |
November 30, 2014 | |
August 31, 2014 | -49.24K% |
May 31, 2014 | |
February 28, 2014 | -1.14K% |
November 30, 2013 | -13.60K% |
August 31, 2013 | -1.22K% |
May 31, 2013 | -30.76K% |
February 28, 2013 | -6.38K% |
November 30, 2012 | -379.7% |
August 31, 2012 | -738.5% |
May 31, 2012 | -11.54K% |
February 29, 2012 | |
November 30, 2011 | |
August 31, 2011 | |
May 31, 2011 | -1.23K% |
February 28, 2011 | -4.29K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.91K%
Minimum
Mar 2021
-3.98K%
Maximum
Dec 2020
-4.44K%
Average
-4.44K%
Median
Profit Margin (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 1.26% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -2.12K% |
Xenon Pharmaceuticals Inc | -- |
ESSA Pharma Inc | -- |